Travel grant 2025, Switzerland, SwissNordicBio 13 mars

Important results from the project

Participation in Swiss Nordic Bio provided valuable insights even though the high-level objective was only partially achieved. The matchmaking service did not meet expectations, especially regarding investor activity. However, the meetings generated insights that are implemented in our strategy. Subsequent contacts have led to new meetings in Stockholm. The project has strengthened our position in the life science network and contributed insights for our development in gene therapy for ALS.

Expected long term effects

Opportunity to raise capital. Opportunity to license our gene therapies.

Approach and implementation

The project focused on participation in Swiss Nordic Bio for networking with investors and pharmaceutical companies. The activities were appropriate and developed according to plan, although the results from the matchmaking service fell short of expectations. The schedule was followed without deviations. When it became clear that the number of meetings via the official service would be limited, I arranged supplementary meetings with my own contacts in Zurich to maximize the value of the trip.